Linkage Projects - Grant ID: LP130100531

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP130100531

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Intracellular trafficking and function of a recycling receptor which prolongs the serum half-life of novel therapeutic proteins. The life span of recombinant engineered proteins for therapeutic use is a critical factor in their effectiveness, ease of clinical application and cost. This project will exploit interactions with a natural receptor, which prolongs the lifespan of serum proteins, to enhance survival of therapeutic engineered proteins.

Funded Activity Details

Start Date: 20-12-2013

End Date: 30-05-2017

Funding Scheme: Linkage Projects

Funding Amount: $495,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) | Medical Biotechnology | Medical Molecular Engineering of Nucleic Acids and Proteins |

ANZSRC Socio-Economic Objective (SEO)

Human Pharmaceutical Products not elsewhere classified | Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified | Expanding Knowledge in the Medical and Health Sciences

Other Keywords

Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) | Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified | Expanding Knowledge in the Medical and Health Sciences | Human Pharmaceutical Products not elsewhere classified | Medical Biotechnology | Medical Molecular Engineering of Nucleic Acids and Proteins

Related Links